These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25252801)

  • 1. In response to: safety and efficacy of flumazenil for reversal of iatrogenic benzodiazepine-associated delirium toxicity during treatment of alcohol withdrawal, a retrospective review at one center.
    Lucyk S; von Schweinitz BA; Hoffman RS
    J Med Toxicol; 2014 Dec; 10(4):435. PubMed ID: 25252801
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and efficacy of flumazenil for reversal of iatrogenic benzodiazepine-associated delirium toxicity during treatment of alcohol withdrawal, a retrospective review at one center.
    Moore PW; Donovan JW; Burkhart KK; Waskin JA; Hieger MA; Adkins AR; Wert Y; Haggerty DA; Rasimas JJ
    J Med Toxicol; 2014 Jun; 10(2):126-32. PubMed ID: 24619543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The toxicologist and delirium: flumazenil as a diagnostic and therapeutic tool for delirium during the course of alcohol withdrawal.
    Moore PW; Hieger MA; Donovan JW
    J Med Toxicol; 2014 Dec; 10(4):436-7. PubMed ID: 25260539
    [No Abstract]   [Full Text] [Related]  

  • 4. Alcohol withdrawal and flumazenil: not for the faint of heart.
    Nelson LS
    J Med Toxicol; 2014 Jun; 10(2):123-5. PubMed ID: 24595919
    [No Abstract]   [Full Text] [Related]  

  • 5. Slow subcutaneous infusion of flumazenil for the treatment of long-term, high-dose benzodiazepine users: a review of 214 cases.
    Faccini M; Leone R; Opri S; Casari R; Resentera C; Morbioli L; Conforti A; Lugoboni F
    J Psychopharmacol; 2016 Oct; 30(10):1047-53. PubMed ID: 27166362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of Adverse Events Using Flumazenil in Patients With Iatrogenic Benzodiazepine Delirium: A Retrospective Study.
    Hieger MA; Moore PW; Maskell KF
    Am J Ther; 2024 Jul-Aug 01; 31(4):e356-e361. PubMed ID: 38976524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flumazenil reversal of lorazepam-induced acute delirium.
    Olshaker JS; Flanigan J
    J Emerg Med; 2003 Feb; 24(2):181-3. PubMed ID: 12609649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study.
    Gerra G; Zaimovic A; Giusti F; Moi G; Brewer C
    Addict Biol; 2002 Oct; 7(4):385-95. PubMed ID: 14578014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flumazenil: a possible treatment for benzodiazepine withdrawal anxiety.
    File SE; Baldwin HA
    Lancet; 1987 Jul; 2(8550):106-7. PubMed ID: 2885562
    [No Abstract]   [Full Text] [Related]  

  • 10. Benzodiazepine dependence and its treatment with low dose flumazenil.
    Hood SD; Norman A; Hince DA; Melichar JK; Hulse GK
    Br J Clin Pharmacol; 2014 Feb; 77(2):285-94. PubMed ID: 23126253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of flumazenil in the treatment of benzodiazepine withdrawal--a double-blind pilot study.
    Saxon L; Hjemdahl P; Hiltunen AJ; Borg S
    Psychopharmacology (Berl); 1997 May; 131(2):153-60. PubMed ID: 9201803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flumazenil in alcohol withdrawal: a double-blind placebo-controlled study.
    Potokar J; Coupland N; Glue P; Groves S; Malizia A; Bailey J; Wilson S; Nutt D
    Alcohol Alcohol; 1997; 32(5):605-11. PubMed ID: 9373703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawal and psychological sequelae, and patient satisfaction associated with subcutaneous flumazenil infusion for the management of benzodiazepine withdrawal: a case series.
    Hulse G; O'Neil G; Morris N; Bennett K; Norman A; Hood S
    J Psychopharmacol; 2013 Feb; 27(2):222-7. PubMed ID: 22596209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flumazenil in alcohol withdrawal.
    Nutt D; Glue P; Wilson S; Groves S; Coupland N; Bailey J
    Alcohol Alcohol Suppl; 1993; 2():337-41. PubMed ID: 7748321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological uses of flumazenil in benzodiazepine use disorders: a systematic review of limited data.
    Gallo AT; Hulse G
    J Psychopharmacol; 2021 Mar; 35(3):211-220. PubMed ID: 33426982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A risk-benefit assessment of flumazenil in the management of benzodiazepine overdose.
    Weinbroum AA; Flaishon R; Sorkine P; Szold O; Rudick V
    Drug Saf; 1997 Sep; 17(3):181-96. PubMed ID: 9306053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzodiazepines revisited--will we ever learn?
    Lader M
    Addiction; 2011 Dec; 106(12):2086-109. PubMed ID: 21714826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iatrogenic benzodiazepine withdrawal delirium in hospitalized older patients.
    Moss JH; Lanctôt KL
    J Am Geriatr Soc; 1998 Aug; 46(8):1020-2. PubMed ID: 9706895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of patients treated with low-dose flumazenil for benzodiazepine detoxification: A description of 26 participants.
    MacDonald T; Gallo AT; Basso-Hulse G; Hulse GK
    Drug Alcohol Depend; 2022 Aug; 237():109517. PubMed ID: 35688053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Sedative Medication Administration and Delirium Development in a Medical Intensive Care Unit.
    Franz ND; Alaniz C; Miller JT; Farina N
    J Pharm Pract; 2023 Oct; 36(5):1164-1169. PubMed ID: 35466784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.